Atara Biotherapeutics ATRA reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Atara Biotherapeutics reported an EPS of $-0.31.
Revenue was up $47.71 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 1.47% increase in the share price the next day.
Here's a look at Atara Biotherapeutics's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.98 | -0.69 | -0.94 | -0.89 |
EPS Actual | -0.87 | -0.96 | -0.90 | -0.91 |
Revenue Estimate | 4.91M | 35.14M | 3.92M | 3.84M |
Revenue Actual | 7.31M | 7.55M | 5.37M | 3.87M |
To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.